Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles

11:46 EDT 18 Mar 2011 |

Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ:ALNY) has been working with Tekmira Pharmaceuticals (TSE:TKM) of Vancouver, BC, since at least 2006 on getting its gene-silencing drugs into cells to treat diseases. But the partnership has gone sour. Tekmira has filed a lawsuit that is seeking what could amount to more than $1 billion from Alnylam. Alnylam, founded [...]

Original Article: Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles


More From BioPortfolio on "Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles"

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...